✦ LIBER ✦

Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations

✍ Scribed by Yuka Sugimoto; Hideki Muramatsu; Hideki Makishima; Courtney Prince; Anna M. Jankowska; Nao Yoshida; Yinyan Xu; Nobuhiro Nishio; Asahito Hama; Hiroshi Yagasaki; Yoshiyuki Takahashi; Koji Kato; Atsushi Manabe; Seiji Kojima; Jaroslaw P. Maciejewski

Book ID: 108676788
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 172 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08196.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations of polycomb-associated gene AS

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia

✍ Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Julien Bonansea; Nathal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Genetic typing of CBL, ASXL1, RUNX1, TET

Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia

✍ Benoîte Pérez; Olivier Kosmider; Bruno Cassinat; Aline Renneville; Julie Lachena 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Quantitative assessment of PTPN11 or RAS

Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia

✍ Kazuyuki Matsuda; Kazuo Sakashita; Chiaki Taira; Miyuki Tanaka-Yanagisawa; Ryu Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

The spectrum of apoptotic defects and cl

The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations

✍ Akshay K. Vaishnaw; Elias Toubi; Satomi Ohsako; Jorn Drappa; Saundra Buys; Jaime 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 2 views

## Objective: To determine the clinical spectrum of disease in humans with mutations in the cd95 (fas/ apo-1) receptor and to obtain mechanistic insight into the different clinical phenotypes observed. ## Methods: Clinical information for each of the index cases, first-degree relatives, and any f